Edition:
India

Fresenius SE & Co KGaA (FREG.DE)

FREG.DE on Xetra

65.28EUR
16 Jan 2018
Change (% chg)

€-0.08 (-0.12%)
Prev Close
€65.36
Open
€65.48
Day's High
€65.82
Day's Low
€65.12
Volume
1,042,750
Avg. Vol
1,459,067
52-wk High
€80.07
52-wk Low
€60.15

Select another date:

Sun, Jan 7 2018

Photo

Fresenius CFO backs acquisition course: Boersen-Zeitung

FRANKFURT German healthcare group Fresenius will continue to look for acquisitions even if that leads to a temporary rise in debt, Boersen-Zeitung quoted the company's finance chief as saying.

Fresenius CFO backs acquisition course -Boersen-Zeitung

FRANKFURT, Jan 7 German healthcare group Fresenius will continue to look for acquisitions even if that leads to a temporary rise in debt, Boersen-Zeitung quoted the company's finance chief as saying.

BRIEF-Fresenius says US Tax Reform ‍results In One-Time Book Gain Of about 90 mln euros

* ‍NEW US TAX LEGISLATION TRIGGERS REVALUATION OF DEFERRED TAX LIABILITIES​

Fresenius says on track to increase dividend again next year

FRANKFURT, Nov 21 German healthcare group Fresenius SE is well on its way to further increase its annual dividend next year, reflecting the prospect of earnings growth in 2017, its chief executive said.

Senvest Management shorting drug stocks Insys, Akorn, Fresenius

TEL AVIV, Oct 3 New York-based Senvest Management is shorting three drug stocks, Insys Therapeutics Inc , Akorn Inc and Fresenius SE, its chief executive Richard Mashaal said on Tuesday,

BRIEF-Fresenius refinances 3.8 bln euro credit agreement

* Credit agreement has volume of around 3.8 billion euros, consists of revolving facilities and term loans with maturities in 2021 and 2022

Fresenius Q2 adjusted earnings jump on new drug launches

FRANKFURT, Aug 1 Diversified German healthcare group Fresenius, controlled by a charitable trust, saw adjusted net income jump 21 percent, bolstered by new drug launches at its U.S. generic infusion division Kabi and by newly-acquired Quironsalud, Spain's largest hospital chain.

Fresenius poaches Telefonica Deutschland CFO Rachel Empey

BERLIN, July 21 Fresenius named Rachel Empey as its chief financial officer on Friday, poaching her from Telefonica Deutschland.

BRIEF-Fresenius SE says Akorn shareholders approved merger

* At yesterday's special meeting, shareholders of Akorn, Inc., have approved merger agreement with fresenius kabi, with 83.9 percent of outstanding shares being voted in favour of transaction. Source text for Eikon: Further company coverage:

BRIEF-Akorn shareholders vote to approve merger agreement with Fresenius Kabi

* Akorn shareholders vote to approve merger agreement with Fresenius Kabi

Select another date: